** Shares of ImpediMed IPD.AX rise 5% to A$0.0525
** Stock set for best session since December 9, 2024, if gains hold
** The medical technology co's unit executes an agreement for a five-year $15 million growth capital facility with SWK Funding
** Co adds that funds raised will be used to support growth and commercialisation activities
** Stock down 3.9% this year, as of last close
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。